Pharmaceutical Executive-07-01-2021

Navigating PV Divergence: Compliance Tips for New Entrants

July 08, 2021

Features

41

7

With small biotechs facing similar expectations as large pharma in drug safety and pharmacovigilance, despite less resources, identifying the key differences between US and EU requirements can help these companies craft a practical path to multi-region compliance.

Building Belonging: Pharma’s New Focus in DE&I

July 08, 2021

Features

41

7

Along with the industry’s massive effort to tackle the health and social problems exposed by COVID, pharma companies have spent the last year addressing the internal impact of racial inequalities following the murder of George Floyd.

Coach First, CEO Second

July 08, 2021

Executive Profile

41

7

Influenced by lessons from the playing field, former rugby athlete James Robinson, today president and CEO of Urovant Sciences, discusses the keys to establishing a high-performing team culture in biopharma—and the end-game wins in treatment gain and patient need.

Questions Linger on COVID’s Origin

July 08, 2021

Chairman’s Letter

41

7

Debate on origin of virus responsible for global pandemic continues on.